Published in J Cell Biol on October 01, 1992
Expression of Protein Kinase C Isoforms in Pancreatic Islets and Liver of Male Goto-Kakizaki Rats, a Model of Type 2 Diabetes. PLoS One (2015) 1.39
Activation of protein kinase C isozymes is associated with post-mitotic events in intestinal epithelial cells in situ. J Cell Biol (1994) 1.36
Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes. Diabetes (2008) 1.33
Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Br J Pharmacol (2008) 1.09
Biphasic insulin secretion from freshly isolated or cultured, perifused rodent islets: comparative studies with rats and mice. Metabolism (2008) 0.99
Mode of regulation of the extracellular signal-regulated kinases in the pancreatic beta-cell line MIN6 and their implication in the regulation of insulin gene transcription. Biochem J (1999) 0.96
Characterization of a novel protein kinase C response element in the glucagon gene. Mol Cell Biol (1997) 0.88
Phosphorylation of SNAP-25 on serine-187 is induced by secretagogues in insulin-secreting cells, but is not correlated with insulin secretion. Biochem J (2002) 0.82
Glucose Evokes Rapid Ca2+ and Cyclic AMP Signals by Activating the Cell-Surface Glucose-Sensing Receptor in Pancreatic β-Cells. PLoS One (2015) 0.79
Studies and perspectives of protein kinase C. Science (1986) 14.73
The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature (1988) 14.43
A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh) (1972) 7.64
Regulation of insulin release by calcium. Physiol Rev (1981) 3.91
Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev (1987) 3.54
Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology (1968) 3.23
Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes (1990) 2.97
Association of type 3 protein kinase C with focal contacts in rat embryo fibroblasts. J Cell Biol (1989) 2.63
Interrelationship of islet metabolism, adenosine triphosphate content and insulin release. Biochem J (1973) 2.48
ATP-sensitive K+ channels in pancreatic beta-cells. Spare-channel hypothesis. Diabetes (1988) 1.82
Glucose and carbachol generate 1,2-diacylglycerols by different mechanisms in pancreatic islets. J Clin Invest (1988) 1.82
A protein kinase C isozyme is translocated to cytoskeletal elements on activation. Cell Regul (1990) 1.69
Inhibition of glucose phosphorylation by mannoheptulose. Biochem J (1964) 1.66
Insulin secretion: combined effects of phorbol ester and A23187. Biochem Biophys Res Commun (1983) 1.64
Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J Clin Invest (1974) 1.55
Intracellular receptors for activated protein kinase C. Identification of a binding site for the enzyme. J Biol Chem (1991) 1.51
Inhibition of ATP-regulated K+ channels precedes depolarization-induced increase in cytoplasmic free Ca2+ concentration in pancreatic beta-cells. J Biol Chem (1987) 1.49
Type 3 protein kinase C localization to the nuclear envelope of phorbol ester-treated NIH 3T3 cells. J Cell Biol (1989) 1.48
Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity. J Clin Invest (1992) 1.41
Glucose-induced translocation of protein kinase C in rat pancreatic islets. Proc Natl Acad Sci U S A (1990) 1.39
Glucose-induced accumulation of inositol trisphosphates in isolated pancreatic islets. Predominance of the 1,3,4-isomer. Biochem J (1986) 1.25
Cell type-specific expression of protein kinase C isozymes in the rabbit cerebellum. J Biol Chem (1988) 1.22
Physiology and pathophysiology of insulin secretion. Diabetes Care (1990) 1.21
Immediate and time-dependent effects of glucose on insulin release from rat pancreatic tissue. Evidence for different mechanisms of action. J Clin Invest (1978) 1.13
Perspectives in diabetes. Is protein kinase C required for physiologic insulin release? Diabetes (1988) 1.09
Control of insulin secretion: a model involving Ca2+, cAMP and diacylglycerol. Mol Cell Endocrinol (1990) 1.08
Translocation of protein kinase C in rat islets of Langerhans. Effects of a phorbol ester, carbachol and glucose. FEBS Lett (1989) 1.02
Phosphoinositide hydrolysis and insulin release from isolated perifused rat islets. Studies with glucose. Diabetes (1988) 1.02
A role for calcium in the breakdown of inositol phospholipids in intact and digitonin-permeabilized pancreatic islets. Biochem J (1986) 0.99
Immunocytochemical evidence for translocation of protein kinase C in human megakaryoblastic leukemic cells: synergistic effects of Ca2+ and activators of protein kinase C on the plasma membrane association. J Cell Biol (1988) 0.99
On the biochemical nature of triose- and hexose-stimulated insulin secretion. Endocrinology (1978) 0.96
Comparison of effects of phorbol esters and glucose on protein kinase C activation and insulin secretion in pancreatic islets. Biochem J (1989) 0.92
Insulin secretion: combined tolbutamide, forskolin and TPA mimic action of glucose. Cell Calcium (1984) 0.91
Different expression of protein kinase C isozymes in pancreatic islet cells. Endocrinology (1990) 0.90
Protein kinase C in insulin releasing cells. Putative role in stimulus secretion coupling. FEBS Lett (1990) 0.90
Glucose-induced phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in isolated rat pancreatic islets. J Biol Chem (1992) 0.87
Activation of protein kinase C is essential for sustained insulin secretion in response to cholinergic stimulation. Biochim Biophys Acta (1991) 0.83
Effects of insulin secretagogues on protein kinase C-catalyzed phosphorylation of an endogenous substrate in isolated pancreatic islets. J Biol Chem (1990) 0.82
Influence of staurosporine on glucose-mediated and glucose-conditioned insulin secretion. Biochem J (1991) 0.80
Cholecystokinin-stimulated insulin secretion and protein kinase C in rat pancreatic islets. Acta Physiol Scand (1991) 0.79
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science (2001) 11.22
Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med (1999) 8.32
Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia (1999) 8.17
Disruption of IRS-2 causes type 2 diabetes in mice. Nature (1998) 7.94
Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet (1998) 7.70
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell (2000) 7.26
Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes (1999) 7.14
Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest (1999) 6.73
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature (2001) 6.70
Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest (1996) 6.50
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A (2001) 5.48
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest (2002) 5.31
Cell communication, calcium ion, and cyclic adenosine monophosphate. Science (1970) 5.25
Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell (2001) 5.13
Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes (2000) 4.80
Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74
Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol (2000) 4.64
Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med (1998) 4.40
Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest (1987) 4.26
Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem (2000) 3.90
Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest (1992) 3.55
Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab (2001) 3.45
Relationships between calcium and cyclic nucleotides in cell activation. Physiol Rev (1977) 3.45
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest (2000) 3.41
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 3.41
Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest (2001) 3.41
Calcium messenger system: an integrated view. Physiol Rev (1984) 3.34
Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med (1996) 2.92
Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science (1991) 2.92
Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation (1997) 2.80
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A (1999) 2.76
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes (1997) 2.76
Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest (2000) 2.75
Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest (2001) 2.68
Cyclic adenosine 3':5'-monophosphate-stimulated phosphorylation of isolated neurotubule subunits. Proc Natl Acad Sci U S A (1970) 2.56
A mechanism for the reactions of calcium with mitochondria. Proc Natl Acad Sci U S A (1965) 2.54
31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 2.52
Cyclic adenosine monophosphate, CA++, and membranes. Proc Natl Acad Sci U S A (1968) 2.46
Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol (1999) 2.44
Conservative management of operable breast cancer: ten years experience at the Foundation Curie. Cancer (1978) 2.31
Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes (1995) 2.30
Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1995) 2.25
Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiol Scand (2000) 2.21
13C/31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes (1998) 2.21
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev (2001) 2.18
Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest (1997) 2.16
Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes (2001) 2.10
Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest (1994) 2.09
Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin Invest (2001) 2.01
Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem (2000) 1.95
Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest (1972) 1.93
Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest (1987) 1.92
Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes (2000) 1.89
Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord (2003) 1.85
Protein kinase C in the regulation of smooth muscle contraction. FASEB J (1987) 1.81
Lack of efficacy of a food-frequency questionnaire in assessing dietary macronutrient intakes in subjects consuming diets of known composition. Am J Clin Nutr (2000) 1.76
The calcium messenger system (2). N Engl J Med (1986) 1.75
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest (1998) 1.75
Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol (1999) 1.75
Further studies on the isolation and charcterization of parathyroid polypeptides. Biochemistry (1966) 1.72
Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J Clin Invest (1995) 1.65
Effects of caffeine on muscle glycogen utilization and the neuroendocrine axis during exercise. J Clin Endocrinol Metab (2000) 1.65
Insulin secretion: combined effects of phorbol ester and A23187. Biochem Biophys Res Commun (1983) 1.64
A rapidly acting metabolite of vitamin D3. Proc Natl Acad Sci U S A (1971) 1.63
A spatial-temporal model of cell activation. Science (1988) 1.63
Localized 13C NMR spectroscopy in the human brain of amino acid labeling from D-[1-13C]glucose. J Neurochem (1994) 1.60
Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest (1996) 1.58
Liver glycogen turnover in fed and fasted humans. Am J Physiol (1994) 1.57
Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest (1996) 1.57
The temporal integration of the aldosterone secretory response to angiotensin occurs via two intracellular pathways. J Biol Chem (1984) 1.55
Role of calcium and adenosine-3':5'-cyclic monophosphate in controlling fly salivary gland secretion. Proc Natl Acad Sci U S A (1972) 1.51
Validation of 13C NMR measurement of human skeletal muscle glycogen by direct biochemical assay of needle biopsy samples. Magn Reson Med (1992) 1.51
Phosphorylation of an endogenous membrane protein by an endogenous, membrane-associated cyclic adenosine 3',5'-monophosphate-dependent protein kinase in human erythrocyte ghosts. J Biol Chem (1972) 1.51
The calcium messenger system (1). N Engl J Med (1986) 1.51
Electrical and adaptive properties of rod photoreceptors in Bufo marinus. II. Effects of cyclic nucleotides and prostaglandins. J Gen Physiol (1977) 1.50
In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism. J Biol Chem (2001) 1.49
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. Clin Cancer Res (1998) 1.48
Induction of intestinal brush border alkaline phosphatase by vitamin D and identity with ca-ATPase. Nature (1970) 1.48
Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet. JAMA (1995) 1.48
Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study. J Clin Invest (1995) 1.47
1H-[13C] NMR measurements of [4-13C]glutamate turnover in human brain. Proc Natl Acad Sci U S A (1992) 1.47
Direct measurement of brain glucose concentrations in humans by 13C NMR spectroscopy. Proc Natl Acad Sci U S A (1992) 1.46
Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance. J Clin Invest (2001) 1.45
TPA-induced contraction of isolated rabbit vascular smooth muscle. Biochem Biophys Res Commun (1984) 1.45
RELATION OF CHEMICAL ATTACHMENT TO PHYSIOLOGICAL ACTION OF VASOPRESSIN. Proc Natl Acad Sci U S A (1960) 1.45
Assessment of mitochondrial energy coupling in vivo by 13C/31P NMR. Proc Natl Acad Sci U S A (2000) 1.44
The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest (1996) 1.41
Impaired cyclic nucleotide-dependent vasorelaxation in human umbilical artery smooth muscle. Am J Physiol (1995) 1.41
The small heat shock-related protein, HSP20, is phosphorylated on serine 16 during cyclic nucleotide-dependent relaxation. J Biol Chem (1999) 1.40
Glucose-induced translocation of protein kinase C in rat pancreatic islets. Proc Natl Acad Sci U S A (1990) 1.39
The role of cyclic AMP and calcium in cell activation. CRC Crit Rev Biochem (1972) 1.38
Contribution of net hepatic glycogenolysis to glucose production during the early postprandial period. Am J Physiol (1996) 1.37
Mechanism of troglitazone action in type 2 diabetes. Diabetes (2000) 1.36
The effects of bombesin on polyphosphoinositide and calcium metabolism in Swiss 3T3 cells. J Biol Chem (1987) 1.35
Crystal structure of a peptide nucleic acid (PNA) duplex at 1.7 A resolution. Nat Struct Biol (1997) 1.35